Innate Pharma developed an mAb with AstraZeneca and is a trusted partner to Sanofi, with BTIG initiating analyst coverage.
2 reports, 2 independent
Updated Aug 14
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Innate Pharma developed an mAb with AstraZeneca and is a trusted partner to Sanofi, with BTIG initiating analyst coverage.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
AstraZeneca
British-Swedish pharmaceutical company
-
Sanofi
company in Milan, Italy
Nothing else this week.
Related events
- Alnylam Pharmaceuticals announced new partnerships with AstraZeneca for drug development and with Ionis Pharmaceuticals for clinical trials.
- AstraZeneca and Innate Pharma S.A. are collaborating on developing a lead pharmaceutical program.
- Amgen acquired Horizon Therapeutics, a company whose portfolio included a drug discovered by AstraZeneca.
- AbbVie, AstraZeneca, and GSK are major players in global drug development, facing challenges in the drug class and pursuing licensing deals with Chinese biotechs.
Coverage
Newest first; wire copies grouped- finanznachrichten.de
- Business WireInnate Pharma Announces Its Participation in the BTIG Virtual Biotechnology Conference MARSEILLE, France, July 29, 2025--(BUSINESS WIRE)--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasda